ImmuCell Corporation Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage
ImmuCell Corporation (ICCC) reported Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage of 100.00% for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage · last filed 2024-08-13
- ImmuCell Corporation deferred compensation arrangement with individual, cash awards granted, percentage for the quarter ending 2024-03-31 was 100.00%.
- ImmuCell Corporation deferred compensation arrangement with individual, cash awards granted, percentage for fiscal 2023 was 100.00%.
| Period end | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 3 month | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 6 month | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 9 month | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 12 month |
|---|---|---|---|---|
| 2024-06-30 | 100.00% 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | 100.00% 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 100.00% 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 100.00% 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 100.00% 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |